Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Restriction Endonucleases Market by Application (Polymerase Chain Reaction (PCR), Restriction Fragment Length Polymorphism (RFLP), Epigenetics, Restriction Digestion, Sequencing, and Cloning) and End User (Hospitals, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Diagnostic Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_184199
Pages: NA
Jun 2018 | 287 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Restriction endonucleases, also known as restriction enzymes, are possess the capability of cutting through a DNA molecule at a given location. These enzymes form the key component of DNA recombinant technology, and are used to scan a DNA molecule for searching specific sequences that commonly comprise of six or four nucleotides. After locating the required DNA sequences, the restriction endonucleases cut the strand, a process which is known at enzyme digestion.

The factors that drive the growth of the restriction endonucleases market are increase in use of restriction endonucleases in various applications such as in vivo gene editing, epigenetic modifications, building DNA libraries, and others. In addition, rise in investment in R&D activities of molecular biology procedures and techniques fuels the market growth. However, high cost of restriction endonucleases production and certain level of unreliability of these enzymes in providing accuracy restrain the market growth. Conversely, well-established molecular biology industry in developed regions such as North America and Europe is anticipated to provide lucrative growth opportunities for the market.

The report segments the restriction endonucleases market based on application, end user, and region. On the basis of application, the market is categorized into polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), epigenetics, restriction digestion, sequencing, and cloning. In terms of end user, it is classified into hospitals, academic research institutes, pharmaceutical, biotechnology companies, diagnostic centers, and clinics. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global restriction endonucleases market are Promega Corporation, ThermoFisher Scientific, Inc., Agilent Technologies, Inc., Genetix Biotech Asia Pvt. Ltd., Inc., New England Biolabs, Affymetrix, Inc., Illumina, Inc., Enzymatics, Inc., Takara Bio, Inc., and Sigma-Aldrich Co. LLC.

Key Benefits

  • The study provides an in-depth analysis of the global restriction endonucleases market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Restriction Endonucleases Market Key Segments:

By Application

  • Polymerase Chain Reaction (PCR)
  • Restriction Fragment Length Polymorphism (RFLP)
  • Epigenetics
  • Restriction Digestion
  • Sequencing
  • Cloning

By End User

  • Hospitals
  • Academic Research Institutes
  • Pharmaceutical
  • Biotechnology Companies
  • Diagnostic Centers
  • Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Argentina
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY APPLICATION 

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. POLYMERASE CHAIN REACTION (PCR)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. EPIGENETICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. RESTRICTION DIGESTION

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. SEQUENCING

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. CLONING

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ACADEMIC RESEARCH INSTITUTES

5.2.1. Market size and forecast

5.3. HOSPITALS

 5.3.1. Market Size And Forecast 

5.4. PHARMACEUTICAL

 5.4.1. Market Size And Forecast 

5.5. BIOTECHNOLOGY COMPANIES

 5.5.1. Market Size And Forecast 

5.6. DIAGNOSTIC CENTER 

 5.6.1. Market Size And Forecast 

5.7. RHEUMATOLOGY 

 5.7.1. Market Size And Forecast 

5.8. CLINICS 

 5.8.1. Market Size And Forecast 

Chapter: 6 GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Restriction Endonucleases Market by Application
6.2.5. North America Restriction Endonucleases Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Restriction Endonucleases Market by Application
6.3.5. Europe Restriction Endonucleases Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Restriction Endonucleases Market by Application
6.4.5. Asia-Pacific Restriction Endonucleases Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. Saudi Arabia market size and forecast
6.5.3.5. South Africa market size and forecast
6.5.3.6. Rest of LAMEA market size and forecast

6.5.4. LAMEA Restriction Endonucleases Market by Application
6.5.6. LAMEA Restriction Endonucleases Market by End User

Chapter: 7 COMPANY PROFILES

7.1. PROMEGA CORPORATION

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. THERMOFISHER SCIENTIFIC, INC.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. AGILENT TECHNOLOGIES, INC.

7.3.1. Operating Business Segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. GENETIX BIOTECH ASIA PVT. LTD., INC

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. NEW ENGLAND BIOLABS

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. AFFYMETRIX, INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. ILLUMINA, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ENZYMATICS, INC.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. TAKARA BIO, INC.

7.9.1. Operating Business Segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. SIGMA-ALDRICH CO. LLC.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Restriction Endonucleases Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts